Welcome Guest | Register / Login

Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Acorda Therapeutics Inc - Key Facts
Acorda Therapeutics Inc - Key Employees
Acorda Therapeutics Inc - Key Employee Biographies
Acorda Therapeutics Inc - Major Products and Services
Acorda Therapeutics Inc - History
Acorda Therapeutics Inc - Company Statement
Acorda Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Company Overview
Acorda Therapeutics Inc - Business Description
Product Category: Ampyra
Overview
Performance
Product Category: Inbrija
Overview
Performance
Product Category: Other
Performance
Product Category: License Revenue
Performance
Product Category: Net Product Revenue
Performance
Product Category: Royalty Revenue
Performance
R&D Overview
Acorda Therapeutics Inc - Corporate Strategy
Acorda Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Acorda Therapeutics Inc - Strengths
Acorda Therapeutics Inc - Weaknesses
Acorda Therapeutics Inc - Opportunities
Acorda Therapeutics Inc - Threats
Acorda Therapeutics Inc - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company's Lifesciences Financial Deals and Alliances
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Acorda Therapeutics Inc, Recent Deals Summary
Section 5 - Company's Recent Developments
Feb 13, 2020: Acorda Therapeutics provides business update and reports fourth quarter and full year 2019 financial results
Jan 15, 2020: Acorda provides 2019 highlights and 2020 guidance at J.P. Morgan Healthcare Conference
Nov 27, 2019: Acorda Therapeutics elects John Kelley Chair, Board of Directors
Nov 12, 2019: Acorda Therapeutics announces departure of President, International & General Counsel
Nov 04, 2019: Acorda provides update for third quarter ended september 30, 2019
Oct 23, 2019: Acorda Therapeutics implements corporate restructuring, provides third quarter 2019 update
Oct 22, 2019: Acorda launches new tool for people with Parkinson's to improve communication about off periods
Aug 01, 2019: Acorda provides update for second quarter ended June 30, 2019
Jun 28, 2019: $21.9 Million gene modulation research effort targets influenza pandemics
Jun 03, 2019: Acorda Therapeutics Debuts Art Exhibition inspired by people with Parkinson's at the 5th World Parkinson Congress
Section 6 - Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Acorda Therapeutics Inc, Key Facts
Acorda Therapeutics Inc, Key Employees
Acorda Therapeutics Inc, Key Employee Biographies
Acorda Therapeutics Inc, Major Products and Services
Acorda Therapeutics Inc, History
Acorda Therapeutics Inc, Other Locations
Acorda Therapeutics Inc, Subsidiaries
Acorda Therapeutics Inc, Key Competitors
Acorda Therapeutics Inc, Ratios based on current share price
Acorda Therapeutics Inc, Annual Ratios
Acorda Therapeutics Inc, Annual Ratios (Cont...1)
Acorda Therapeutics Inc, Annual Ratios (Cont...2)
Acorda Therapeutics Inc, Interim Ratios
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Acorda Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Acorda Therapeutics Inc, Performance Chart (2015 - 2019)
Acorda Therapeutics Inc, Ratio Charts
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Acorda Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
Single User License: Report will be emailed in PDF format and can be accessed by a specific user. This License type allows the report to be Printed.
Site License: Report will be emailed in PDF and  allows only employees within the same geographical location within the organization to access it. This License type allows the report to be Printed.
Global Site License: Report will be emailed in PDF format and allows all employees within the organization to access it.  This License type allows the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :GlobalData
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy